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Purpose: The aim of the study was to investigate the effect of hydro-alcohol coating solvent ratio on the 
surface texture and lag time of porous theophylline osmotic tablet.  
Methods: Porous theophylline osmotic pump tablets were formulated by direct compression and coated 
by spraying with varying ratios of water-alcohol containing hydroxypropyl methylcellulose (HPMC, 5 cps) 
as primary swelling layer and Eudragit
®
 RSPO and RLPO as porous layer. The viscosity of HPMC 
coating solution was determined using Brookfield viscometer. Surface morphology was investigated with 
scanning electron microscopy (SEM). In vitro drug release studies to assess lag time was performed in 
simulated gastric fluid (SGF) and simulated intestinal fluid (SIF). 
Results: No significant change in the viscosity of HPMC coating solution was found when water-alcohol 
solvent ratio was varied. SEM revealed profound distortions in coating texture with a high proportion of 
either solvent in the coating solution. Increasing the amount of either water or alcohol in the coating 
solution increased the roughness of coated surface which contributed to a burst release of drug due to 
early opening of the tablet as a result of the high osmotic pressure and low mechanical strength of the 
coated layer. The optimum coating solvent ratio for spray-coating the osmotic tablets was water : alcohol 
(60:34) and it resulted in a coating with smooth texture and which successfully modulated drug release 
lag time of the coated tablets.   
Conclusion: The optimum ratio of water/alcohol (60:34) as coating solvent produced a smooth coated 
tablet surface texture and modulated the drug release lag time of the tablets. 
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INTRODUCTION 
 
Hydro-alcohol solvent systems are 
extensively used in the pharmaceutical field 
to apply functional and/or nonfunctional 
coating of tablets. Good product 
performance, including uniformity of coating 
and drug release, is a strong function of 
these coatings. Uniformity of tablet coating is 
extremely important as it affects the 
organoleptic quality of tablets and 
functionality of the coating, especially for 
modified release formulations
1,2
. The texture 
of coated membranes can affect drug release 
and lag time, which are important parameters 
in modified-release oral dosage forms
1-3
. 
Among modified-release oral dosage forms, 
increasing interest has been shown in 
systems designed to achieve time-specific 
(delayed, pulsatile) and site-specific delivery 
of drugs
4,5
. In particular, systems for delayed 
release are meant to deliver the active 
principle after a programmed period following 
administration. These systems constitute a 
relatively new class of devices, the 
importance of which is especially connected 





By now it is well-known that the 
symptomatology of a large number of 
pathologies as well as the pharmacokinetics 
and pharmacodynamics of several drugs 
follow temporal rhythms, often resulting in 
circadian variations. Therefore, the possibility 
of exploiting delayed release to perform 
chronotherapy is quite appealing for those 
diseases. The delay in the onset of release 
has so far mainly been achieved through 
osmotic mechanism, coating with hydrophilic 
or hydrophobic layers as swellable and semi 
permeable films, swelling, and erodible plug 
sealing of insoluble capsule body
7
. In 
addition, multiple coating technology has 
been applied to chronopharmaceutical 
dosage forms to achieve the desired lag time 




In the present investigation, a combination of 
approaches was used to develop the coated 
tablet formulation. HPMC was applied as a 
swelling layer while Eudragit RSPO/RLPO 
was used to provide a semi-permeable 
membrane for delayed release. The study 
mainly focused on the investigation of the 
influence of hydro-alcohol coating solvent 
ratio (water/ethanol) on the surface texture 
and drug release lag time of a coated porous 
osmotic tablet. Theophylline (TP), which is a 
useful drug in the management of nocturnal 
asthma, was used as the test drug in view of 
its effectiveness when administered at 









Theophylline (Bukul Aromatics and 
Chemicals., India) was chosen as the model 
drug for this study; methacrylic acid co-
polymers (Eudragit
®
 RS-PO and RL-PO) 
were supplied free of charge by JJ-Degussa 
Chemicals, Malaysia. Triethylcitrate [TEC] 
(Fluka, Germany) was selected as plasticizer 
while hydroxylpropyl methylcellulose 
(Methocel E5) was obtained free of charge 
from Colorcon Asea Specific, Singapore. 
Low-substituted hydroxypropyl cellulose was 
received as a gift from Shin-Etsu Chemicals, 
Japan. Sodium chloride (RM Chemicals, 
Malaysia) was used as the osmotic agent. All 





As mentioned in the introduction, the 
objective of the work was to study the effect 
of solvent ratio on coating texture and the lag 
time for drug release. The designed osmotic 
tablet will be further developed to follow 
pulsatile release. The designed pulsatile 
tablet is based on combination of two 
approaches previously attempted: swelling 
and osmotic pumping mechanism. The 
pulsatile tablet was fabricated into three 
stages: first, the drug (TP) was directly 
compressed with the osmotic agent (NaCl) 
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and super-disintegrant (LHPC-LH-11); 
second, tablets were coated with a low 
viscosity swelling layer (HPMC-E5); third, the 
tablets were subsequently coated with pH-
independent methacrylic acid copolymers 
(Eudragit RSPO and RLPO) as a semi-
permeable membrane with TEC as pore 
forming agent. 
 
Preparation of core tablets  
 
Tablet cores containing theophylline [TP] 
(5mg/tablet) were prepared according to the 
following composition (w/w): theophylline 
(5%), sodium chloride (30%), microcrystalline 
cellulose (MCC) [34%], low-substituted 
hydroxypropyl cellulose (L-HPC-LH-11) 
[30%], magnesium stearate (0.5%) and talc 
(0.5%). Sodium chloride was pre-screened 
through a sieve with an aperture of 120µ. 
Magnesium stearate and talc were similarly 
screened through a sieve with an aperture of 
250µ. All the ingredients were mixed for 15 
min and sieved through a mesh with an 
aperture of 420µ five times. Tablets were 
directly compressed from the mixture using 
6.05 mm shallow-concaved punches on Clit-
Press High Speed tablet machine 
(Chemunda Pharma Machine, India). 
Compression force was set such to yield 
tablets with a hardness of 4.5 ± 0.5 kg/cm
2
. 
Tablet hardness was monitored using a tablet 
hardness tester (model YD-2, Vanguard 
Pharmaceutical machinery Inc, China).  
 
Preparation of coating formulations 
 
Varying ratios of water and alcohol (as shown 
in Table 1) were mixed and HPMC (5%  w/w) 
dispersed in each of the solvent by stirring at 
room temperature for 5 h. Polyethylene glycol 
(PEG 400) [1% w/w] was then added and 
stirred for 15 min. 
 
Eudragit RSPO/RLPO blends (see Table 1) 
were similarly prepared at room temperature 
by adding the polymers slowly to the solvent 
with stirring. TEC, talc and PEG 6000 were 
added and stirred further for 30 min. 
 
The viscosity of HPMC coating solution was 




The tablets were warmed in an oven for 15 
min at 45 ± 0.5 
O
C and transferred to a 
coating facility (Kothari Pharma Overseas, 
India). HPMC was applied as a swelling layer 
by spraying. After drying for 15 min in an 
oven at 50.0 ± 0.5 
o
C, the tablets were 
coated with the Eudragit formulation to 
provide a semi-permeable membrane, based 
on the coating parameters shown in Table 1. 
The ratio of Eudragit RS to RL was 2:1. The 
coating level was determined based on the 
weight gain of 20 placebo tablets, which were 
coated at the same time as the test tablets. 




C for 4 h to remove residual solvent from the 
coating.  
 
Assessment of the morphology of coated 
tablet surface  
 
Double layer coated tablets were coated with 
gold on one side by an ion sputter coater 
(Polaron SC515, Fisons Instruments, UK) at 
50 mA for 120 sec. Gold coated surface of 
tablet was evaluated by scanning electron 
microscopy (Leo Supra 50 VP, Germany) to 
assess the surface texture of the Eudragit 
polymer layer. 
 
In vitro evaluation of drug release lag time  
 
In vitro drug release (dissolution) studies 
were performed as per USP paddle method 
at 37.0 ± 0.5
o
C in simulated gastric fluid 
(SGF, pH 1.2) and simulated intestinal fluid 
(SIF, pH 6.8) with the paddle rotating at 100 
rpm. Samples (5 mL) were withdrawn at 
predetermined time intervals and replaced 
with equal volume of media. The 
concentration of TP released from the coated 
tablets was measured by UV absorption 
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Table 1: Coating parameters 
 
Parameter HPMC Layer Eudragit RS and RL Layer 
Batch size (g) 50  50  
Spray rate 2 ml/ min 1ml/ min 
Product temperature 40-44
O










Rotating rate 20 rpm  20 rpm 







HPMC / PEG 400  
5 : 1  
Eudragit RS and RL/TEC/ talc 
/PEG 6000 
5.0 : 0.5 : 0.3 : 0.04 
Water/ethanol        F1 
                               F2 
                               F3 











All dissolution tests were performed in 
triplicate. For each sample, a linear 
regression was carried out on the linear part 
of the dissolution curve. Dissolution rate was 
computed as the slope of the regression line 
while lag-time is the extrapolated intersection 




Viscosity of HPMC coating solution: 
 
No significant change was found in the 
viscosity of HPMC solution prepared with 
varying ratios of hydroalcohol solutions. 
Viscosity was 5.5 ± 0.1, 5.6 ± 0.12, 5.6 ± 0.2, 
and 5.7 ± 0.1 cps (mean ± SD, n=3) for 
water/alcohol ratio of 80:14, 60:34, 45:49, 
and 30:64, respectively. This indicates that 
drug release lag time would not have been 
influenced by the viscosity of HPMC coating 
solution. 
   
In vitro theophylline release lag time 
 
In vitro release lag time data for the osmotic 
tablets in SGF (see Fig 1) and SIF (see Fig 2) 
did not differ significantly (P < 0.05). Tablets 
coated with polymers based on water/alcohol 
solvent ratios of 80:14 (F1) and 30:64 (F4) 
showed burst drug release, while tablets 
coated with polymers based on water/alcohol 
solvent ratios of 60:34 (F2) exhibited 
increased lag time of approx. 6 h compared 
to tablets coated with polymer based on 
water/alcohol solvent ratios of 45:49 (F3) 
which also showed delayed release followed 
by burst release. F2 showed further extended 




























Fig 1: Comparative in vitro release profiles of 
tablets in SGF coated with coating solution 
containing different ratio of water and alcohol, in 
simulated intestinal fluid at pH 6.8. (F1 = ▬; F2 = 
□; F3 = ◊; F4 = ∆). 
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Fig 2: Comparative in vitro release profiles of 
tablets in SIF coated with coating solution 
containing different ratio of water and alcohol, in 
simulated intestinal fluid at pH 6.8. (F1 = ▬; F2 = 
□; F3 = ◊; F4 = ∆). 
 
 
Surface morphology of coated tablets 
 
The surface morphology and cross-sectional 
view of coated tablets evaluated by SEM are 
shown in Fig 3. Tablets coated with polymers 
using water/alcohol solvent ratios 80:14  and 
30:64 resulted in a rough surface with cracks 
(see Fig 3a and Fig 3d) while those based on 
water/alcohol ratio of 60:34 showed the 
smoothest surface (see Fig 3b) with very fine 
pores. The coating solution based on a 
water/alcohol ratio of 45:49 showed a slightly 




Directly compressed theophylline tablets can 
be easily coated with hydro-alcohol coating 
formulations of HPMC and methacrylic acid 
co-polymers using spray coating method. The 
surface morphology of the tablets was 
satisfactory for those coated with 
formulations based on water/alcohol solvent  
 
  
   
   
  
 
Fig 3: Scanning electron micrographs of tablet surface coated with HPMC and Eudragit RS and RL in 
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ratio of 60:34 (Fig 3b) leaving a good film 
formation on the tablet core
11
. Increasing 
either the amount of water or alcohol in the 
coating solution beyond this ratio resulted in 
increase in coated surface roughness (F1 
and F4) as shown in Figs 3a and 3d. 
Roughness of coated surface contributed to 
decreased drug release lag time which could 
be due to the formation of fractures in the 
coated layer as a result of low mechanical 
strength
13,14
. These fractures might have 
facilitated rapid movement of dissolution 
media into the tablets since high osmotic 
pressure exists across the membrane and 
dissolution media due to the presence of 
osmotic agent (NaCl) in the tablet core. 
 
Surface roughness of the coated film (see Fig 
3a) was high in tablets coated with the 
formulation based on water/alcohol ratio of 
80:14 (F1). The roughness and fracture of F1 
coated tablets could be due to the prolonged 
presence of residual solvent on the surface of 
the tablet as a result of slow evaporation rate 
and sticking of the tablets to the coating pan 
during the tablet coating process. Slow 
evaporation in F1 could be due to the high 
proportion of water in the coating solvent 
system. On the other hand, the rough surface 
of tablets coated with formulation based on 
water/alcohol solvent ratio of 30:64 (F4), as 
shown in Fig 3d, can be attributed to the 
rapid rate of solvent evaporation (due to the 
high alcohol content of the solvent system), 
which did not allow formation of continuous 
coating film, thus
 
leaving behind cracks after 
tablet during drying. Rapid evaporation is 
attributed to the presence of a high proportion 
of volatile ethanol. This contrasts with coated 
tablets based water/alcohol solvent ratio of 
60:34 (F2) which gave a smooth surface (Fig 
3b) as the alcohol proportion of the solvent 
mixture seems appropriate for optimum 
solvent evaporation, resulting in the formation 
of a smooth film coating. Such a smooth film 
would be expected to show resistance to 
penetration of dissolution medium and hence 
passage of dissolution fluid into the tablet 
core, leading to increased lag time
12
. 
Coated tablets based on water/alcohol 
solvent ratio of 45:49 (F3) showed moderate 
surface smoothness (Fig 3c). This may be 
due to the higher proportion of alcohol than in 
coating formulation F2 which leads to a faster 
evaporation of coating solvent than the 
optimum solvent evaporation rate observed 
for F2. Expectedly, cracks and pores in the 
coating resulted in burst release for F1 and 
F4 coating formulation.  
 
The lack of significant difference (p < 0.05) 
between the lag time in simulated gastric fluid 
(pH 1.2) and simulated intestinal fluid (pH 
6.8) may be due to the outer coat which are 
composed of methacrylic acid co-polymers 
whose solubility are pH-independent
15
. The 
similarity of the viscosity of HPMC solutions 
prepared with varying water/alcohol solvent 
mixtures would also mean that ratio of the 
solvent mixture would be unlikely to affect 






Based on the foregoing, it can be concluded 
that the formulation of theophylline osmotic 
tablets for pulsatile release with the desired 
lag time is feasible if the water/alcohol 
solvent ratio for HPMC and methacrylic acid 
co-polymers is carefully selected. In this 
regard, an optimum water/alcohol solvent 
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